Skip to Content

Cerner Corp CERN

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Cerner Unlikely to Be Affected Long-Term by VA Strategic Review; Implementation to Resume in 2022

Dylan Finley, CFA Equity Analyst

Analyst Note

| Dylan Finley, CFA |

Narrow-moat Cerner reported solid second-quarter results and provided insight into the short- and long-term revenue impact resulting from the Department of Veterans Affairs' strategic review of its electronic health record modernization program. As a reminder, it was announced in March 2021 that the VA would temporarily pause the $16 billion rollout of its EHR modernization project with Cerner, expected to be completed by 2028, while a review is launched into the program. The VA inspector general has noted several issues with implementation thus far--partially as a result of the agency's preparedness--resulting in higher costs, delays, and frustration among clinicians. Last week, the VA published a comprehensive report finding implementation issues were related to user training and governance, rather than technology issues with Cerner's EHR. The department announced it would continue to pause the EHR implementation program through the remainder of 2021 and would work closely with Cerner to ensure readiness at future sites beginning in 2022.

Read Full Analysis

Company Profile

Business Description

Cerner is a leading supplier of healthcare information technology solutions and tech-enabled services. The company is a long-standing market leader in the electronic health record industry, and along with rival Epic Systems corners a majority of the market for acute care EHR within health systems. The company is guided by the mission of the founding partners to provide seamless medical records across all healthcare providers to improve outcomes. Beyond medical records, the company offers a wide range of technology that supports the clinical, financial, and operational needs of healthcare facilities.

Contact
2800 Rockcreek Parkway
North Kansas City, MO, 64117
T +1 816 221-1024
Sector Healthcare
Industry Health Information Services
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 28, 2020
Stock Type Classic Growth
Employees 26,400

Related

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.